About Oystershell Life Sciences Private Limited
Data last updated:
Oystershell Life Sciences Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 15 June 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U63999DL2017PTC319257. Its GSTIN is 07AACCO5208K2ZE (Delhi). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹60 Lakh and a paid-up capital of ₹30 Lakh. It is led by directors including Anjana Saxena and Sohan.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at H.No.C – 1 Old No 297 3rd Floor, Unit No 106 Budh Vihar Tajpur Pahari, New Delhi, Delhi, India – 110044.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.11 Cr. For the same year it recorded a net profit of ₹2.64 Lakh (net margin 2.4%) and EBITDA of ₹3.74 Lakh (EBITDA margin 3.4%). Revenue has grown at a compounded annual rate (CAGR) of 207% over three years and 41% over five years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website oystershell.in.
Company details
CIN history
Oystershell Life Sciences has one previous CIN (Corporate Identification Number): U51909DL2017PTC319257. The current CIN is U63999DL2017PTC319257, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U63999DL2017PTC319257 | Current |
| U51909DL2017PTC319257 | Previous |
Contact details
Oystershell Life Sciences Private Limited's registered office is in New Delhi, Delhi.
- Registered AddressH.No.C – 1 Old No 297 3rd Floor, Unit No 106 Budh Vihar Tajpur Pahari, New Delhi, Delhi, India – 110044
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Oystershell Life Sciences is information and communication. In detail, this covers other information & communication service activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| J | Information and communication | J8 | Other information & communication service activities |
To see the full business activity and turnover split of Oystershell Life Sciences Private Limited, buy the company report.
Financials of Oystershell Life Sciences Private Limited
FY 2024 filings availableOystershell Life Sciences Private Limited reported revenue of ₹1.11 Cr for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 41% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.74 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.64 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.4% | ||||
| Net Profit Margin | 2.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Oystershell Life Sciences Private Limited, buy the company report.
Board of directors of Oystershell Life Sciences Private Limited
Oystershell Life Sciences has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anjana Saxena | Director | 27 May 2024 | 2 Years 5 Months | Current |
| Sohan | Director | 03 Jun 2024 | 2 Years 4 Months | Current |
| Rahul Thakur | Director | 16 Jan 2025 | 1 Years 9 Months | Current |
Peer comparison
Oystershell Life Sciences Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (other information & communication service activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Gloriosa Infotel IT Services India Private Limited | ₹1.11 Cr (FY 2024) | -32.0% | Thanjavur, Tamil Nadu, India | |||
| Alfie Software Private Limited | ₹1.11 Cr (FY 2024) | -6.0% | Chennai, Tamil Nadu, India | |||
| Atto Innovations Private Limited | ₹1.11 Cr (FY 2025) | 118.0% | Kochi, Kerala, India | |||
| Ievision IT Services Private Limited | ₹1.11 Cr (FY 2025) | 59.0% | Pune, Maharashtra, India | |||
| Trustling Services Private Limited | ₹1.11 Cr (FY 2025) | -55.0% | Navi Mumbai, Maharashtra, India | |||
| Oystershell Life Sciences Private Limitedthis company | ₹1.11 Cr (FY 2024) | ₹2.64 Lakh | 2.4% | New Delhi, Delhi, India | ||
| Cyberlytics Systems Private Limited | ₹1.11 Cr (FY 2024) | -13.0% | Bangalore, Karnataka, India | |||
| Mindzkonnected Technologies Private Limited | ₹1.11 Cr (FY 2024) | 447.0% | Noida, Uttar Pradesh, India | |||
| Missiondidis Private Limited | ₹1.11 Cr (FY 2024) | 101.0% | Mumbai, Maharashtra, India | |||
| Inscomont Services Private Limited | ₹1.11 Cr (FY 2025) | 40.0% | Pune, Maharashtra, India | |||
| Techrowth Private Limited | ₹1.11 Cr (FY 2023) | Bengaluru, Karnataka, India |
To see the full peer comparison of Oystershell Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Oystershell Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Oystershell Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Oystershell Life Sciences has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AACCO5208K2ZE | Delhi | Active | 18 Nov 2024 |
To see the full GST registrations and return filing status of Oystershell Life Sciences Private Limited, buy the company report.
Recent activity
Oystershell Life Sciences Private Limited has 8 board changes on record since 2017: 3 appointments and 5 cessations. The latest: Rahul Thakur was appointed as Director on 16 Jan 2025.
Frequently asked questions
Oystershell Life Sciences is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 15 June 2017 (9+ years old) and is registered under CIN U63999DL2017PTC319257.
Oystershell Life Sciences has 3 current directors:
- Anjana Saxena - Director
- Sohan - Director
- Rahul Thakur - Director
The latest financial statements of Oystershell Life Sciences on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Oystershell Life Sciences is 07AACCO5208K2ZE, registered in Delhi. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Oystershell Life Sciences is U63999DL2017PTC319257. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Oystershell Life Sciences was incorporated on 15 June 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Oystershell Life Sciences by revenue are Gloriosa Infotel IT Services India Private Limited, Alfie Software Private Limited, Atto Innovations Private Limited, Ievision IT Services Private Limited, Trustling Services Private Limited and 5 more, all in the same principal business activity (other information & communication service activities).
Rahul Thakur was appointed as Director on 16 Jan 2025. Sohan ceased to be Director on 16 Jan 2025. Shiv Kumar Goel ceased to be Director on 04 Jun 2024. Oystershell Life Sciences has 8 board changes on record in total.
Oystershell Life Sciences can be reached through the website oystershell.in. Its registered office is in New Delhi, Delhi, India.
The registered office of Oystershell Life Sciences is at H.No.C – 1 Old No 297 3rd Floor, Unit No 106 Budh Vihar Tajpur Pahari, New Delhi, Delhi, India – 110044.
Oystershell Life Sciences operates in the pharma industry, in the pharmaceutical retailers and distributors segment.